Stay updated on M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial
Sign up to get notified when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.

Latest updates to the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check32 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check68 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a clinical study on the influenza vaccine M-001, while adding new information about the study's location and collaborators.SummaryDifference36%
Stay in the know with updates to M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.